[{"Name": "TruthGundlach", "Time": "20191111", "Text": "No question Josh Allen has a cannon arm but he\u2019s yet to connect on a deep vertical route in his Bills career!Every try\u2019s been a wasted down."}, {"Name": "TruthGundlach", "Time": "20191111", "Text": "Josh Allen has had receivers open on the vertical many times this season. To his credit he has read it. But he has not once made the throw."}, {"Name": "FundyLongShort", "Time": "20191111", "Text": "@LibertyRPF Yup."}, {"Name": "PresciencePoint", "Time": "20191111", "Text": "Much of our continued bullishness is driven by increased optimism over the potential for $MDXG's micronized amnioti\u2026 https://t.co/v3kQIwOR0m"}, {"Name": "PresciencePoint", "Time": "20191111", "Text": "Prescience Point remains $MDXG's largest shareholder and, as of Nov 11th, owns ~[7.7]% of @MiMedx\u2019s outstanding sha\u2026 https://t.co/ZdxDblAM4u"}, {"Name": "JohnHuber72", "Time": "20191111", "Text": "I thought Dimon had a good point here. People tend to always think the current time is more unpredictable than usua\u2026 https://t.co/vqmHls6RFI"}, {"Name": "PresciencePoint", "Time": "20191111", "Text": "As a recent example, in Nov 2019, @AmerAcadPainMed published a study showing that micronized amniotic injections si\u2026 https://t.co/Dn1seBpHoi"}, {"Name": "PresciencePoint", "Time": "20191111", "Text": "We believe that $MDXG will eventually receive approval for both indications given the substantial and mounting evid\u2026 https://t.co/GXAL8iueF6"}, {"Name": "PresciencePoint", "Time": "20191111", "Text": "@AmerAcadPainMed The injectable market for joints exceeds $12B annually &amp; Amniofix is far ahead of competing produc\u2026 https://t.co/Y19RIbFSfQ"}, {"Name": "JohnHuber72", "Time": "20191111", "Text": "@HarvardWinters Why do you think that? I think we have a tendency to always think we are at a critical juncture, ju\u2026 https://t.co/CswKIbGVDp"}]